Results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have included “outdated information” and that could mean the company provided an incomplete view of efficacy data, U.S. federal health officials said early Tuesday.
AstraZeneca trial results may have included ‘outdated’ information, U.S. health officials say
